Issuer Free Writing Prospectus dated November 18, 2026
Filed Pursuant to Rule 433
Relating to Preliminary Prospectus dated November 17, 2026
Registration Nos. 333-299633 and 333-300148
980,000,000 Shares of Class A Common Stock
| | | | | |
| Issuer: | Anthropic, PBC |
| Symbol: | ANT (Nasdaq Global Select Market) |
| Size (excluding Option to Purchase Additional Shares): | $81,340,000,000 |
| Base Shares Offered by Anthropic: | 956,351,354 shares of Class A common stock |
| Base Shares Offered by Selling Stockholders: | 23,648,646 shares of Class A common stock |
| Option Shares Offered: | Up to 147,000,000 shares of Class A common stock (100% Primary) |
| Concurrent Private Placement: | $26.0 billion of Class N common stock (313,253,007 shares) at the price to public. |
| Price to Public: | $83.00 per share |
| Price to Underwriters: | $82.43878 per share (base shares only); the underwriters will not receive any underwriting discounts or commissions on shares sold pursuant to their option to purchase additional shares |
| Pricing Date: | November 18, 2026 |
| Trade Date: | November 19, 2026 |
| Settlement Date: | November 20, 2026 |
| CUSIP No: | 03703U 107 |
| Lead Bookrunning Managers: | Goldman Sachs & Co. LLC Morgan Stanley & Co. LLC |
| Bookrunning Managers: | J.P. Morgan Securities LLC Citigroup Global Markets Inc. Barclays Capital Inc. and Barclays Bank PLC Wells Fargo Securities, LLC BofA Securities, Inc. Deutsche Bank Securities Inc. RBC Capital Markets, LLC UBS Securities LLC |
| | | | | |
| |
| Co-Managers: | BMO Capital Markets Corp. BNP Paribas Securities Corp. Credit Agricole Securities (USA) Inc. Jefferies LLC Mizuho Securities USA LLC MUFG Securities Americas Inc. TD Securities (USA) LLC BTIG, LLC Cantor Fitzgerald & Co. Capital One Securities, Inc. Macquarie Capital (USA) Inc. SG Americas Securities, LLC |
****
This free writing prospectus relates to the initial public offering of Class A common stock of Anthropic, PBC (“Anthropic”) and should be read together with the preliminary prospectus dated November 17, 2026 (the “Preliminary Prospectus”) included in Amendment No. 3 (“Amendment No. 3”) to the Registration Statement on Form S-1 (File No. 333-299633) relating to the offering of such securities. Amendment No. 3 may be accessed through the following link: https://www.sec.gov/Archives/edgar/data/2130357/000162828026074338/anthropicpbc-sx1ax3.htm. This free writing prospectus supplements and updates the information contained in the Preliminary Prospectus. You should read the Preliminary Prospectus carefully, including the section entitled “Risk Factors,” before deciding to invest in Anthropic’s Class A common stock. Capitalized and other terms used but not defined herein have the meanings set forth in the Preliminary Prospectus. Anthropic has filed registration statements (including the Preliminary Prospectus) with the Securities and Exchange Commission (the “SEC”) for the initial public offering of its Class A common stock to which this communication relates. The registration statement on Form S-1 (File No. 333-299633) was declared effective on November 18, 2026, and the related registration statement on Form S-1 filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended (File No. 333-300148), became effective upon filing on November 18, 2026. Before you invest, you should read the Preliminary Prospectus and other documents Anthropic has filed with the SEC for more complete information about Anthropic and its initial public offering of Class A common stock. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, Anthropic, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it from: Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at (866) 471-2526, or by email at prospectus-ny@ny.email.gs.com; or Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014, or by email at prospectus@morganstanley.com.
This communication shall not constitute an offer to sell or the solicitation of any offer to buy, nor shall there be any sale of the securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.